{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:48:35Z","timestamp":1778539715349,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T00:00:00Z","timestamp":1504051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011103","name":"Sixth Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000341","name":"Arthritis Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000341","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Myositis UK"},{"name":"Project for Conceptual Development of Research Organization"},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000782","name":"European Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000782","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1136\/annrheumdis-2017-211868","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T01:00:23Z","timestamp":1504141223000},"page":"30-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":241,"title":["The EuroMyositis registry: an international collaborative tool to facilitate myositis research"],"prefix":"10.1016","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9230-4137","authenticated-orcid":false,"given":"James B","family":"Lilleker","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0851-0713","authenticated-orcid":false,"given":"Jiri","family":"Vencovsky","sequence":"additional","affiliation":[]},{"given":"Guochun","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Lucy R","family":"Wedderburn","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2581-8912","authenticated-orcid":false,"given":"Louise Pyndt","family":"Diederichsen","sequence":"additional","affiliation":[]},{"given":"Jens","family":"Schmidt","sequence":"additional","affiliation":[]},{"given":"Paula","family":"Oakley","sequence":"additional","affiliation":[]},{"given":"Olivier","family":"Benveniste","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9608-2252","authenticated-orcid":false,"given":"Maria Giovanna","family":"Danieli","sequence":"additional","affiliation":[]},{"given":"Katalin","family":"Danko","sequence":"additional","affiliation":[]},{"given":"Nguyen Thi Phuong","family":"Thuy","sequence":"additional","affiliation":[]},{"given":"Monica","family":"Vazquez-Del Mercado","sequence":"additional","affiliation":[]},{"given":"Helena","family":"Andersson","sequence":"additional","affiliation":[]},{"given":"Boel","family":"De Paepe","sequence":"additional","affiliation":[]},{"given":"Jan L","family":"deBleecker","sequence":"additional","affiliation":[]},{"given":"Britta","family":"Maurer","sequence":"additional","affiliation":[]},{"given":"Liza J","family":"McCann","sequence":"additional","affiliation":[]},{"given":"Nicolo","family":"Pipitone","sequence":"additional","affiliation":[]},{"given":"Neil","family":"McHugh","sequence":"additional","affiliation":[]},{"given":"Zoe E","family":"Betteridge","sequence":"additional","affiliation":[]},{"given":"Paul","family":"New","sequence":"additional","affiliation":[]},{"given":"Robert G","family":"Cooper","sequence":"additional","affiliation":[]},{"given":"William E","family":"Ollier","sequence":"additional","affiliation":[]},{"given":"Janine A","family":"Lamb","sequence":"additional","affiliation":[]},{"given":"Niels Steen","family":"Krogh","sequence":"additional","affiliation":[]},{"given":"Ingrid E","family":"Lundberg","sequence":"additional","affiliation":[]},{"given":"Hector","family":"Chinoy","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1136\/annrheumdis-2017-211868_bib1","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMra1402225","article-title":"Inflammatory muscle diseases","volume":"372","author":"Dalakas","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1136\/annrheumdis-2017-211868_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/joim.12451","article-title":"Myositis-specific autoantibodies: an important tool to support diagnosis of myositis","volume":"280","author":"Betteridge","year":"2016","journal-title":"J Intern Med"},{"key":"10.1136\/annrheumdis-2017-211868_bib3","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/mus.23302","article-title":"Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan","volume":"45","author":"Furst","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1136\/annrheumdis-2017-211868_bib4","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1177\/1759720X16655126","article-title":"Selected aspects of the current management of myositis","volume":"8","author":"Lilleker","year":"2016","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1136\/annrheumdis-2017-211868_bib5","article-title":"Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis","volume":"8","author":"Gordon","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1136\/annrheumdis-2017-211868_bib6","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s10067-015-3059-y","article-title":"The evidence for immunotherapy in dermatomyositis and polymyositis: a systematic review","volume":"34","author":"Vermaak","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1136\/annrheumdis-2017-211868_bib7","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/01.bor.0000434667.55020.e1","article-title":"Registries in idiopathic inflammatory myopathies","volume":"25","author":"Lundberg","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"10.1136\/annrheumdis-2017-211868_bib8","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/BOR.0000000000000119","article-title":"Myositis registries and biorepositories: powerful tools to advance clinical, epidemiologic and pathogenic research","volume":"26","author":"Rider","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1136\/annrheumdis-2017-211868_bib9","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1136\/annrheumdis-2015-208119","article-title":"Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups","volume":"75","author":"Rothwell","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2017-211868_bib10","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1136\/annrheumdis-2016-210282","article-title":"Cytosolic 5'-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis","volume":"76","author":"Lilleker","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2017-211868_bib11","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1002\/art.38463","article-title":"A47: Progress Report on the Development of New Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies","volume":"66","author":"Pilkington","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/annrheumdis-2017-211868_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/rheumatology\/keg427","article-title":"International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease","volume":"43","author":"Isenberg","year":"2004","journal-title":"Rheumatology"},{"key":"10.1136\/annrheumdis-2017-211868_bib13","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1212\/WNL.0000000000001422","article-title":"Nuclear actin aggregation is a hallmark of anti-synthetase syndrome-induced dysimmune myopathy","volume":"84","author":"Stenzel","year":"2015","journal-title":"Neurology"},{"key":"10.1136\/annrheumdis-2017-211868_bib14","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.autrev.2016.07.023","article-title":"Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study","volume":"15","author":"Musset","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1136\/annrheumdis-2017-211868_bib15","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/ana.24902","article-title":"Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies","volume":"81","author":"Arouche-Delaperche","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1136\/annrheumdis-2017-211868_bib16","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1136\/ard.2006.052191","article-title":"Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy","volume":"65","author":"Hengstman","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2017-211868_bib17","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and Dermatomyositis","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med Overseas Ed"},{"key":"10.1136\/annrheumdis-2017-211868_bib18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1136\/annrheumdis-2017-211868_bib19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.nmd.2009.11.003","article-title":"Inclusion body myositis: MRC centre for neuromuscular Diseases, IBM workshop, London, 13 June 2008","volume":"20","author":"Hilton-Jones","year":"2010","journal-title":"Neuromuscul Disord"},{"key":"10.1136\/annrheumdis-2017-211868_bib20","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ana.410380504","article-title":"Inclusion body myositis and myopathies","volume":"38","author":"Griggs","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1136\/annrheumdis-2017-211868_bib21","series-title":"Diagnostic Criteria for Neuromuscular Disorders","first-page":"81","article-title":"Inclusion body myositis","author":"Verschuuren","year":"1997"},{"key":"10.1136\/annrheumdis-2017-211868_bib22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2017-211868_bib23","first-page":"581","article-title":"Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","volume":"23","author":"Preliminary criteria for the classification of systemic sclerosis (scleroderma)","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2017-211868_bib24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2017-211868_bib25","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/art.1780360309","article-title":"Preliminary criteria for the classification of Sj\u00f6gren's syndrome. Results of a prospective concerted action supported by the European Community","volume":"36","author":"Vitali","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2017-211868_bib26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0738-081X(94)90336-0","article-title":"Mixed connective tissue disease and overlap syndromes","volume":"12","author":"Alarc\u00f3n-Segovia","year":"1994","journal-title":"Clin Dermatol"},{"key":"10.1136\/annrheumdis-2017-211868_bib27","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1378\/chest.10-0180","article-title":"Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?","volume":"138","author":"Connors","year":"2010","journal-title":"Chest"},{"key":"10.1136\/annrheumdis-2017-211868_bib28","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/00002281-200311000-00006","article-title":"Skin involvement in dermatomyositis","volume":"15","author":"Santmyire-Rosenberger","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"10.1136\/annrheumdis-2017-211868_bib29","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/clpt.2014.121","article-title":"Phenotype standardization for statin-induced myotoxicity","volume":"96","author":"Alfirevic","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"10.1136\/annrheumdis-2017-211868_bib30","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","article-title":"Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients","volume":"84","author":"Troyanov","year":"2005","journal-title":"Medicine"},{"key":"10.1136\/annrheumdis-2017-211868_bib31","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/ard.2006.068502","article-title":"The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis","volume":"66","author":"Chinoy","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2017-211868_bib32","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1136\/annrheumdis-2012-202857","article-title":"Anakinra treatment in patients with refractory inflammatory myopathies and possible predictive response biomarkers: a mechanistic study with 12 months follow-up","volume":"73","author":"Zong","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2017-211868_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2016-000291","article-title":"Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies","volume":"2","author":"Schwartz","year":"2016","journal-title":"RMD Open"},{"key":"10.1136\/annrheumdis-2017-211868_bib34","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/annrheumdis-2011-200182","article-title":"Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study","volume":"71","author":"Chinoy","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2017-211868_bib35","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1002\/art.22751","article-title":"Seasonal birth patterns in myositis subgroups suggest an etiologic role of early environmental exposures","volume":"56","author":"Vegosen","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2017-211868_bib36","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/art.24702","article-title":"Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women","volume":"60","author":"Love","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2017-211868_bib37","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1093\/rheumatology\/keq277","article-title":"Environmental factors preceding illness onset differ in phenotypes of the juvenile idiopathic inflammatory myopathies","volume":"49","author":"Rider","year":"2010","journal-title":"Rheumatology"},{"key":"10.1136\/annrheumdis-2017-211868_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/acr.23198","article-title":"Predictors of Reduced Health-Related Quality of Life in Adult Patients with Idiopathic Inflammatory Myopathies","author":"Feldon","year":"2017","journal-title":"Arthritis Care Res"},{"key":"10.1136\/annrheumdis-2017-211868_bib39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/joim.12524","article-title":"Diagnosis and classification of idiopathic inflammatory myopathies","volume":"280","author":"Lundberg","year":"2016","journal-title":"J Intern Med"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724010252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724010252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/annrheumdis-2017-211868","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T08:23:47Z","timestamp":1739521427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724010252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0003496724010252"],"URL":"https:\/\/doi.org\/10.1136\/annrheumdis-2017-211868","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The EuroMyositis registry: an international collaborative tool to facilitate myositis research","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/annrheumdis-2017-211868","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 \u00a9 Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}